Financial Data and Key Metrics Changes - The company's net loss for Q1 2025 was $37 million, or $0.86 per share, compared to a net loss of $21.6 million, or $0.64 per share for Q1 2024 [20] - Non-GAAP adjusted net loss was $34.7 million, or $0.81 per share for Q1 2025, compared to a non-GAAP adjusted net loss of $19.9 million, or $0.59 per share for Q1 2024 [20] - Research and development expenses increased to $32.2 million for Q1 2025 from $20.6 million in Q1 2024, with a significant portion attributed to clinical trial activities [20][21] - General and administrative expenses rose to $3.9 million for Q1 2025 from $1.8 million in Q1 2024 [21] - Net cash used in operating activities was $35.9 million for Q1 2025, compared to $17.1 million for Q1 2024 [22] - The company ended the quarter with approximately $205.7 million in cash, cash equivalents, and short-term investments [22] Business Line Data and Key Metrics Changes - The company is focused on three clinical programs, with significant revenue potential if regulatory approvals are obtained [7][8] - The Phase III VICTORIA-one trial is designed to evaluate gadotelisib in combination with fulvestrant for advanced breast cancer patients [9] - The VICTORIA-two trial is a global Phase III study evaluating gadotelisib as a first-line treatment for HR positive, HER2 negative advanced breast cancer [15][16] - The Phase 1B2 trial is assessing gadotelisib in combination with darolutamide for metastatic castration-resistant prostate cancer [17] Market Data and Key Metrics Changes - The company estimates that nearly 200,000 late-stage cancer patients globally would be eligible for treatment with gadotelisib if approved [8] - The peak revenue potential for the second-line indication of gadotelisib could exceed $2 billion with just 40% market penetration [15] Company Strategy and Development Direction - The company aims to transition to a commercial stage company following potential FDA approvals for its clinical programs [10] - The focus is on developing effective therapies for advanced breast cancer patients resistant to endocrine therapy, addressing a significant unmet need in the market [16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the upcoming clinical data readouts, with top-line data expected from the VICTORIA-one trial in Q3 2025 [7][10] - The company recognizes the importance of demonstrating clinically meaningful results in terms of progression-free survival (PFS) to gain market acceptance [12][14] Other Important Information - The company is collaborating with Dana Farber Cancer Institute and Massachusetts General Hospital to evaluate gadotelisib in endometrial cancer [18] - The company expects its current cash reserves to fund clinical development activities through 2026 [22] Q&A Session Summary Question: Timing for VICTORIA-one data readout - Management expects to lock the database in June and report results in Q3 2025, with no anticipated delays [27][28][30] Question: Impact of SERNA6 on second-line setting - Management believes SERNA6 will not affect their patient population as it pertains to first-line CDK4/6 patients [36][37] Question: Minimum HR for wild type update - Management indicated that an incremental three months in PFS would be considered clinically meaningful, but specifics will not be disclosed until data is available [39][40] Question: Change in timing for wild type readout - Management clarified that variability in event distribution among trial arms influenced the timing, but they remain confident in the Q4 timeline for the PIK3CA mutant population [43][44] Question: Prior proof of concept data for prostate cancer - Management discussed the encouraging non-clinical data supporting the efficacy of gadotelisib compared to single-node inhibitors [47][49]

Financial Data and Key Metrics Changes - The company reported adjusted EPS of $6.04 per share for Q1 2025, down from $7.15 per share in Q1 2024, reflecting a decrease in adjusted net income from $140 million to $113.4 million, a decline of $26.6 million [11] - Total operating costs increased by $19.8 million, primarily due to a rise in the average number of vessels in the fleet, while net finance costs rose by $6 million [11][12] - Adjusted EBITDA decreased by 3.1% or $5.5 million to $171.7 million compared to $177.2 million in Q1 2024 [14] Business Line Data and Key Metrics Changes - Revenues from the drybulk segment decreased by $9 million due to a softer spot market, while container segment revenues fell by $9.4 million due to lower contracted charter rates [11] - Fleet utilization decreased, contributing to a $6.4 million drop in revenues, mainly due to increased dry dockings [11] Market Data and Key Metrics Changes - The drybulk market has shown modest recovery from its lows, but a meaningful recovery is challenging without further growth initiatives in China [6] - The Pacific market has experienced a dramatic decline due to tariff uncertainties and ongoing armed conflicts, particularly between India and Pakistan [5] Company Strategy and Development Direction - The company is focusing on optimizing the performance of its existing fleet and investing in energy-saving devices to enhance competitiveness [20] - A significant growth backlog includes 15 container vessels scheduled for delivery over the next three years, all backed by profitable charter arrangements [9] - The company is holding off on new vessel investments due to the current environment of expensive new builds and unclear future fuel options [21] Management's Comments on Operating Environment and Future Outlook - Management noted that the U.S. economy remains resilient, with expectations of a rebound in trade flows as consumer spending continues [6] - The proposed IMO regulation on greenhouse gas emissions is seen as insufficient to drive meaningful progress in decarbonization, leading to uncertainty in future fuel options [8] Other Important Information - The company declared a dividend of $0.85 per share for the quarter and has repurchased $36.9 million worth of stock, totaling $205.7 million in share repurchases to date [15] - As of March 31, 2025, cash stood at $480 million, with total liquidity at $825 million, providing flexibility for capital deployment opportunities [15] Q&A Session Summary Question: Focus on cash generation or investment opportunities in existing fleet? - Management confirmed a focus on investing in energy-saving devices to enhance competitiveness while also generating significant cash [20] Question: Continuation of stock buybacks? - Management indicated that there is $100 million authorized for buybacks, but no specific targets or timelines were set for execution [22] Question: Reason for increasing stake in Star Bulk? - The additional investment in Star Bulk was seen as a compelling opportunity, with no specific plans for the time being [23][24]

FRP (FRPH) Q1 2025 Earnings Call May 13, 2025 09:00 AM ET Company Participants Matthew Mcnulty - CFO & TreasurerDavid deVilliers - President & COOJohn Baker III - CEO Operator Good day, everyone, and welcome to the FRP Holdings Inc. Twenty twenty five First Quarter Earnings Call. At this time, all participants are in a listen only mode. Later, there will be a question and answer session. Please be advised that today's call is being recorded. Should you require operator assistance, you may press 0. I'd now l ...

Financial Data and Key Metrics Changes - Net income for Q1 2025 increased by 31.4% to $1,700,000 or $0.09 per share compared to $1,300,000 or $0.07 per share in the same period last year [5] - Pro rata share of net operating income (NOI) increased by 10% year over year to $9,400,000, driven by higher contributions from multifamily developments and mining royalty segments [5][6] - Over the last three years, pro rata NOI has grown at a compound annual growth rate of 21.8% [6] Business Line Data and Key Metrics Changes - The multifamily segment contributed an additional $141,000 of NOI year over year [5] - The mining segment saw an increase of $524,000 in NOI [5] - The industrial and commercial segment NOI decreased by $20,000 year over year due to tenant eviction [6][7] - Mining and royalty business segment revenues and NOI increased by 919% to $3,200,000 and $3,300,000 respectively [8] - Multifamily segment revenues and NOI totaled $14,300,000 and $8,000,000 respectively, with FRP's share being $8,300,000 and $4,600,000 [9] Market Data and Key Metrics Changes - The commercial and industrial segment had a total of nine buildings with 85.2% leased and occupied [7] - The multifamily apartments were 94% occupied, while retail space was 74.8% occupied [9] - The average rental rate of expiring industrial leases was $6.55 triple net, with expectations for new rates to start in the sevens or greater [18] Company Strategy and Development Direction - The company aims to double the size of its industrial segment over the next five years, with a focus on new industrial projects [23] - Development projects include a 258,000 square foot warehouse in Maryland and a 200,000 square foot warehouse in Florida [11][12] - The company plans to continue entitlement work on its industrial pipeline in Maryland to be shovel-ready by 2026 [22] Management's Comments on Operating Environment and Future Outlook - Management cautioned investors to expect flat to slightly negative NOI results overall in 2025 due to temporary headwinds [21] - The company is focused on getting existing properties fully occupied and investing in new projects to set up for future NOI growth [21][24] - Uncertainty around trade policy and the economy has caused leasing activity to slow, but rental rates remain strong [17] Other Important Information - The company has committed $31,100,000 in funding for the Aberdeen overlook project, with expected profits of $11,200,000 [16] - The company is in the initial permitting stage for a 55-acre tract in Harbour County, Maryland, with plans for four buildings totaling 635,000 square feet [14] Q&A Session Summary - There were no questions from participants during the Q&A session [25]

Financial Data and Key Metrics Changes - In Q1 2025, the company raised $75 million in cash from BC Partners through an investment in a subsidiary, with an option for an additional $75 million for future acquisitions [5] - General and administrative expenses totaled $6 million, including $2 million related to evaluating potential transactions and $3 million in stock issuance costs directly tied to the BC Partners investment [5] - The company closed the quarter with $222 million in cash, cash equivalents, and marketable securities, up from $149 million at the end of fiscal year 2024 [6] Business Line Data and Key Metrics Changes - The company incurred approximately $5 million in cash on transaction-related costs during the quarter, which was offset by interest income of approximately $2 million [6] Market Data and Key Metrics Changes - No specific market data or key metrics changes were provided in the call [9] Company Strategy and Development Direction - The company is focused on maintaining low cash expenses to maximize available cash for organic growth and acquisitions, aiming to build a strong and durable business [6] - Following the strategic investment from BC Partners, the company is actively identifying growth and acquisition opportunities, with BC Partners enhancing the pipeline of opportunities [7] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the receptiveness of potential partners and the quality of inbound outreach, indicating a positive outlook for future growth [7] Other Important Information - The company emphasized its commitment to keeping cash expenses low and highlighted the collaborative efforts with BC Partners to explore growth opportunities [6][7] Summary of Q&A Session - There was no question and answer session at the conclusion of the call [9]

Financial Data and Key Metrics Changes - In Q1 2025, the company raised $75 million in cash from BC Partners, with an additional option for $75 million to fund future acquisitions [5] - The company incurred $6 million in general and administrative expenses, including $2 million related to evaluating potential transactions [5] - Cash expenses were offset by approximately $2 million in interest income, resulting in a closing cash balance of $222 million, up from $149 million at the end of fiscal year 2024 [6] Business Line Data and Key Metrics Changes - The company has focused on maintaining low cash burn to maximize available cash for growth and acquisitions, indicating a strategic shift towards a more sustainable business model [6] Market Data and Key Metrics Changes - The strategic investment from BC Partners has expanded the company's pipeline of opportunities and enhanced its capabilities, reflecting a positive market reception [7] Company Strategy and Development Direction - The company is committed to organic growth and acquisitions, with a strong emphasis on identifying growth opportunities in collaboration with BC Partners [6][7] - Management expressed optimism about the quality of inbound outreach and potential partnerships, indicating a proactive approach to market expansion [7] Management's Comments on Operating Environment and Future Outlook - Management highlighted the importance of keeping cash expenses low to support future growth and acquisitions, demonstrating a cautious yet optimistic outlook for the business [6] - The collaboration with BC Partners is expected to yield significant opportunities, with management looking forward to sharing progress in upcoming quarters [7] Other Important Information - The company incurred $3 million in costs directly related to the BC Partners investment, recorded as stock issuance costs, indicating a strategic investment in future growth [5] Summary of Q&A Session - There was no question and answer session at the conclusion of the call, as indicated in the opening remarks [4]

Rackspace Technology, Inc. (NASDAQ:RXT) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Sagar Hebbar - Head of IR Amar Maletira - CEO Mark Marino - CFO Conference Call Participants Irwin Liu - Evercore Operator Good day, and thank you for standing by. Welcome to the Rackspace First Quarter 2025 Earnings Webcast. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. [Operator Instructions] I would ...

Sight Sciences Inc (SGHT) Q1 2025 Earnings Call May 08, 2025 04:30 PM ET Company Participants None - ExecutivePaul Badawi - Founder, CEO & DirectorAli Bauerlein - CFOThomas Stephan - Vice PresidentMatt Link - CCOMacauley Kilbane - Equity Research Associate Conference Call Participants None - AnalystFrank Takkinen - Senior Research AnalystDavid Saxon - Senior Analyst Operator Good day, and thank you for standing by. Welcome to the SITE Sciences first quarter two thousand twenty five earning results conferenc ...

Liquidity Services (LQDT) Q2 2025 Earnings Call May 08, 2025 10:30 AM ET Company Participants Michael Patrick - Vice President and ControllerWilliam Angrick - Chief Executive Officer and Chairman of the Board of DirectorsJorge Celaya - EVP & CFOGary Prestopino - Managing Director Conference Call Participants George Sutton - Partner & Senior Research Analyst Operator Welcome to the Liquidity Services, Inc. Second Quarter of Fiscal Year twenty twenty five Financial Results Conference Call. My name is Michelle ...

Nextdoor Investor Update - Q1 2025 investors.nextdoor.com 1 John T. Williams, Head of IR 3 Nirav Tolia, CEO 4 2 Disclaimer Certain statements in this Investor Update may be considered "forward-looking statements" within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as "may," "should," "expect," "intend," "will," "estimate," "anticipate," "believe," "predict," "project," ...